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A simple High Performance Liquid Chromatography procedure is detailed for 
the purification of Glutathione S-transferase. The human placental transferase 
was used to assess its potential. Unlike conventional methods of 
purification, the procedure is rapid and resolution of the various forms is 
achieved in less than 20 min. Since recovery is essentially complete, it is 
possible to isolate different minor forms. Three forms, one major and two 
minor, were separated. The major form represented about 97% of the total 
recovered activity and exhibited a specific activity of 254.94 umoles/min/mg 
protein with a purification of 1342-fold. Electrophoresis of the major form 
revealed the presence of a single band, suggesting homogeneity. 0 1985 Academic 
Press, Inc. 
GSHTr are a group of enzymes that catalyze the conjugation of GSH with 
numerous electrophiles in the initial step of mercapturic acid formation (1). 
The importance of GSHTr in the activation and detoxification of various 
xenobiotics is well established (2). The presence of different isozymes in 
various tissues is extensively documented. Jakoby et al. (3) have recently -- 
recommended that each isozyme be characterized biochemically. 
Current procedures for the purification of GSHTr rely on a series of 
column chromatographic techniques and other methods, such as ammmonium sulfate 
precipitation, and IEF. However, these methods are tedious and inefficient. 
For example, DEAE-cellulose chromatography requires up to 38 hrs and results 
in only 10 - 53% recovery of enzyme (4-8). Gel filtration, CM-cellulose 
The following abbreviations were used: HPLC, High Performance Liquid 
Chromatography; GSHTr, Glutathione S-transferasecs) (E-C. 2.5.1.18); IEF, 
isoelectric focusing; CDNB, 1-Chloro-2,4-dinitrobenzene; GSH, reduced 
glutathione; DTT, dithiothreitol; PAGE, polyacrylamide gel electrophoresis. 
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chromatography, and chromatofocusing each require approximately 13 - 18 hrs 
and yield 34 - 95%, 59%, and 40% recovery, respectively (4-7,9-ll), while IEF 
may take up to 96 hr and results in only 10% recovery (6,8,12). A possible 
concomitant loss of certain labile forms, due to poor recovery, is another 
aspect which has not been adequately addressed. 
Although Vander Jagt et al. (13) reported a recovery of 85 - 95% with 
affinity chormatography, this procedure cannot resolve different isozymes of 
GSHTr. The presence of subpopulations of specific isozymes has been shown. 
However, due to lack of appropriate methodology, detailed characterization was 
not possible (4,9). 
In light of the shortcomings of previously used techniques, we herein 
describe a HPLC procedure which is rapid, offers high resolution, and results 
in complete recovery of enzymatic activity. Human placental GSHTr was 
selected to evaluate its applicability, since the presence of a single enzyme 
has been reported (6,8,13-15). 
MATERIALS AND METHODS 
CDNB was purchased from Aldrich (Milwaukee, WI.). GSH and DTT were 
obtained from United States Biochemical Co. (Cleveland, OH.). The Sepharose 
4B, and 2-mercaptoethanol were from Sigma Chemical Co. (St. Louis, MO.). All 
other chemicals used were of ACS grade and obtained commercially. 
Enzyme Assay 
GSHTr activity was determined spectrophotometrically, using an Aminco DW- 
2, according to the method of Vander Jagt et al. (13), with slight - 
modification. The reaction mixture consisted of FrnM CDNB, 2.5 mM GSH, 0.1 M 
potassium phosphate buffer, pH 6.5, and a rate-limiting quantity of enzyme in 
3 ml. After a 3 min pre-incubation at 37 OC, the reaction was initiated by the 
addition of CDNB. Incubation mixture without enzyme served as control. The 
linear increase in absorbance at 340 nm was monitored at 37 'C. One enzyme 
unit (U) is defined as 1 pmole of CDNB-conjugate formed per min (extinction 
coefficient of 9.6/mM/cm). Specific activity is reported as U per mg protein. 
Protein content of the placental cytosol was determined according to method of 
Lowry et al. (16), while the dye binding assay of Bradford (17) was used in -- 
subsequent purification steps. 
Enzyme Isolation 
Term placentas from healthy women were obtained immediately after 
parturition and processed within one hour. The following procedures were 
carried-out at 4 OC unless specified otherwise. Chorionic tissue (150 g) was 
teased free of connective tissue, washed copiously with 50 mM Tris buffer 
containing 0.25 M sucrose, pH 7.4 (Buffer A) to remove residual blood 
components, and homogenized in 750 ml of Buffer A using a Waring blender. The 
homogenate was centrifuged at 12,250 x g for 20 min and the resulting 
supernatant was then centrifuged at 100,000 X g for 60 min. The post- 
76 
Vol. 128, No. 1, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
microsomal supernatant served as the starting material for affinity 
chromatography. 
Affinity Chromatography 
The epoxy-activated Sepharose 48 was synthesized according to the method 
of Porath (18) and the GSH was coupled to the activated 4B as described by 
Simans and Vander Jagt (19). In a typical experiment, approximately 200 U 
were applied to the 4B-GSH column (2.8 X 8 cm), which was previously 
equilibrated with 50 mM Tris buffer, pH 7.4 at 4OC (Buffer B). Flow rate was 
maintained at 0.5 ml/min. The column was then washed with Buffer B until no 
protein was detectable in the effluent. The GSHTr was eluted from the matrix 
with 50 mM Tris buffer containing 10 mM GSH, pH 9.6 at 4 'C and collected in 1 
ml fractions. Those fractions exhibiting GSHTr activity were pooled and the 
PH was adjusted to 7.4 with 1 M potassium phosphate monobasic. 
High Performance Liquid Chromatography 
The HPLC system consisted of an Altex model 420 microprocessor with two 
ISCO model 825 metering pumps, a Rheodyne model 7125 sample injector, and a 
Spectra-Monitor III variable UV detector set at 280 nm. The mobile phase 
consisted of 5.5 mM citrate potassium phosphate buffer containing 1 mM DTT and 
10 mM GSH, pH 5.85 (Buffer C) and Buffer D containing 0.4 M KC1 in Buffer C. 
Prior to chromatography the 4B-GSH eluent was concentrated using a PM-15 
membrane, and then dialyzed overnight against 10 mM potassium phosphate buffer 
containing 10 mM GSH, pH 6.0. An aliquot (0.1 - 2 ml) was injected onto the 
anion exchange column (Synchrom AX-300 from Synchrom, Linden, IN.) and eluted 
with a salt gradient. The program was as follows: flow rate of 1 ml/min and 
% Buffer D = 0 at time 0; % Buffer D was increased to 7.5 in 3 min, beqinning 
at time 5 min; % Buffer D was further increased to 100 in 0.1 min at 8 min; 
and re-equilibration began at 16 min, at which time % Buffer D was decreased 
to 0 over 2 min and flow (1.5 ml/min) was maintained for 15 min. The HPLC 
effluent was collected in 1 ml fractions and assayed for GSHTr activity. Those 
fractions exhibiting distinct GSHTr activity peaks were combined and specific 
activity was determined. 
Electrophoresis 
PAGE was performed according to the method of Davis (20), with slight 
modification. Included in the running buffer was 10 mM GSH. A current of 25 
mA/qel was applied. Gels were fixed overnight in isopropanol : glacial acetic 
acid : water (25:10:65, v/v) and stained in a 0.05 % solution of Coomassie 
Blue R-250 in isopropanol : glacial acetic acid : water (25:10:65, v/v) for 3 
hrs. All gels were destained by diffusion using 7 % glacial acetic acid. 
RESULTS 
Table 1 summarizes the results of the purification of GSHTr from five 
term placentas, using the two step procedure. Affinity chromatography 
resulted in substantial purification (533-fold) with a recovery of 97% (Table 
1). These results are similar to those reported by Vander Jagt et al. (13). -__ 
Although this initial step eliminates hemoglobin, a known inhibitor (14), it 
does not yield a homogeneous GSHTr preparation. The presence of several 
proteins bands upon PAGE (Fig. 1) suggests that various proteins are adsorbed 
by the affinity matrix and co-elute with placental GSHTr. 
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Table 1: Purification of Human Placental CSHTr 
Fraction 
Specific Activity* Recovery 
(~moles/min/mg) Purification (%I 
Supernatant 0.19 ? 0.02 1 
4B-CSH 101.29 ? 13.88 533 
HPLC 254.94 +_ 17.34** 1342 
*Values reported are mean t S.E.M. (n=5) 




Our preliminary experiments on the optimization of HPLC conditions 
indicated that the inclusion of various protective agents, such as GSH and 
DTT, in the elution buffers was essential for retention of biological activity 
and acceptable yield of GSHTr. In the absence of such agents, the enzyme 
recovery was only 2.7% of the concentrated 4B-GSH applied. With the inclusion 
of GSH, recovery increased to approximatsly 75%. Addition of 1 mM 
mercaptoethanol, 5% glycerol, or 1 mM DTT to the elution buffers in order to 
supplement the 10 mM GSH present resulted in 49%, 83%, and 111% recovery of 
Figure 1: Polyacrylamide Gel Electrophoresis of Human Placental Glutathione 
S-transferase 
100 ug of protein of each fraction was applied. A, 100,000 x $3 
supernatant: B, concentrated 4B-GSH eluent; C, concentrated HPLC P 2. 
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Figure High Performance Liquid Chromatoqraphic Separation of Human 
Placental Glutathione S-transferase 
154 pg of concentrated 4B-GSH eluent was applied to the Synchrom AX-300 
column. See Material and Methods for details. 
the applied activity, respectively. Therefore, all subsequent experiments were 
performed using 10 mM GSH and 1 mM DTT in the mobile phase. 
The GSHTr present in the 4B-GSH concentrate were resolved into 3 
distinct, active peaks by HPLC. The chromatographic profile obtained from a 
typical experiment is depicted in Figure 2. About 97% of the recovered GSHTr 
activity was present in the major peak (P 2), with a retention time of 5.8 
min. The observed average specific activity of 255 U/mq protein for P 2 
represents an overall purification of 1342-fold (Table 1). Two additional 
minor peaks with retention times of about 3.0 (P 1) 
consistantly observed. They represented approximate1 
of the activity. 
The retention times (mean + S-E., n=5) of 3.23 + - - 
13.96 + 0.17 min were observed for P 1, P 2, and P - 
and 13.4 (P 3) min were 
y  1% (P 1) and 2% (P 3) 
0.43, 6.00 + 0.43, and - 
3. respectively. Re- 
chromatography of fraction 6 of P 2 (Fig. 2), under identical conditions, 
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yielded a peak with a retention time of 5.8 min, containing 99% of the 
activity, demonstrating that HPLC separation was reproducible. 
In contrast to the presence of six bands in the concentrated 4B-GSH 
preparation (Fig. lB), a single band was observed with the concentrated HPLC P 
2 fraction (Fig. lC), suggesting homogeneity. 
DISCUSSION 
Several anomalies exist in the reported properties of highly purified 
human placental GSHTr. The values cited for the molecular weight of the dimer 
vary from 45,000 to 60,000 daltons (6,8,14,15,21,22) and that for the subunit 
range from 22,000 to 23,400 (13,15,21,22). A p1 of 4.5 to 4.9 has been 
observed (6,8,11,14,15,21,22). This variability may, in part, be attributed 
to the possible heterogeneity of the preparations used. Differences in these 
parameters may also arise from different proportions of multiple conformers 
(13,14) present. 
The presence of 3 distinct peaks of GSHTr activity (Fig. 2) suggests that 
the placental transferase is comprised of multiple conformers. Earlier, 
Polidoro et al ---..L (14) did report the existence of 2 interconvertible forms 
using PAGE; whereas, Vander Jagt et al. (13) demonstrated kinetically the -- 
existence of three comformational states. We believe the minor band that 
Polidoro et al. -- (14) observed corresponds to P 3 (Fig. 2), since both are 
relatively more anionic in nature. P 1 interacts minimally with the anion 
exchange resin and may be the cationic form reported by Koskelo (11) or 
another weakly anionic form of placental GSHTr. However, the possibility that 
this may be one of the two forms of erythrocyte GSHTr (23) cannot be 
discounted at this time. Further investigations are in progress to determine 
the physical and biochemical properties of P 2 and P 3. 
The reported HPLC procedure requires less than 20 min and is highly 
reproducible. Up to 1 mg of concentrated 4B-GSH eluent (112 U) can be 
injected onto the column without any significant loss in resolution. Thus, 
the major advantages of the HPLC procedure are rapid separation, excellent 
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resolution, and complete recovery of enzymatic activity. We believe that 
HPLC, with the necessary minor modifications, can be used to resolve and 
quantitatively recover different isozymes as well as conformers of GSHTr from 
various tissues. The potential versatility of this technique is presently 
being evaluated in our laboratory. 
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